Early Trial Results for Remdesivir Show Promise in COVID-19 Treatment

Comments 1041 Views
Covid-19 Gilead Drug Trial

Covid-19 Gilead Drug Trial

In short
The National Institute of Allergy and Infectious Diseases trial reportedly found that Remdesivir Accelerates Recovery from Advanced COVID-19 and that patients had a 31 per cent faster time to recovery than those who received placebo.

 

IP: 35.168.62.171. Referrer: . FirstClickFree: 0. Clicks by IP: ?. Clicks by cookie: ?.